OQROGet OQRO Pro
Insider trade

Moderna (MRNA)Chief Legal Officer sold ~$726K

Shannon Thyme Klinger, Chief Legal Officer at Moderna, sold ~$726K of Moderna shares.

~$726K
Approx. value · 14K sh @ $52.29
60K
Holds after · shares reported
Traded
Mar 2, 2026
Filed
Mar 3, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 12, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  2. Feb 5, 20265% stakeFMR LLC reported a passive stake (13G) of 7.2%
  3. Feb 6, 20265% stakeFMR LLC reported a passive stake (13G) of 10.6%
  4. Feb 9, 20265% stakeBAILLIE GIFFORD & CO reported a passive stake (13G) of 5.3%
  5. Feb 13, 2026Company filing · Form 8-K · ResultsReported its results
  6. Feb 23, 2026InsiderOfficer sold ~$7.81M of MRNA shares in the open market
  7. Mar 2, 2026 · this disclosureInsiderOfficer sold ~$726K of MRNA shares in the open market

What came next

  1. Mar 3, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
  2. Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  3. Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 6.5%
  4. May 1, 2026Company filing · Form 8-K · ResultsReported its results
  5. May 1, 2026InsiderDirector sold ~$265K of MRNA shares in the open market
  6. May 6, 2026Company filing · Form 8-K · Bylaws or charter, Shareholder voteChanged its bylaws, charter or fiscal year, and held a shareholder vote
  7. May 15, 2026InsiderOfficer sold ~$2.58M of MRNA shares in the open market
  8. May 21, 2026InsiderDirector sold ~$434K of MRNA shares in the open market
  9. Jun 4, 2026InsiderOfficer sold ~$174K of MRNA shares in the open market
  10. Jun 15, 2026InsiderOfficer sold ~$2.74M of MRNA shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Moderna

For Moderna, OQRO holds 13 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports and 7 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MRNA page.

Other recent filings by Shannon Thyme Klinger, Chief Legal Officer

The full history of Shannon Thyme Klinger, Chief Legal Officer is on the profile page.

How this filing works

Other disclosures at Moderna

Everything OQRO holds on this company is on its MRNA page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data